---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-106322"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2024-10-04T23:59:59+00:00"
generated_at: "2026-05-30T20:37:49.950370+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Two directors resign from Petros Pharmaceuticals board without disagreement

## Summary
- John Shulman resigned as director effective Oct 1, 2024; no disagreement cited.
- Greg Bradley resigned as director effective Oct 2, 2024; no disagreement cited.
- No replacements announced; remaining board composition unclear.

## SEC filing metadata
- accession: 0001104659-24-106322
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2024-10-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465924106322/0001104659-24-106322-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465924106322/tm2425618d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-106322
- JSON: https://secwatch.observer/filing/0001104659-24-106322.json
- Plain text: https://secwatch.observer/filing/0001104659-24-106322.txt

## Key facts
- Executive change
  John Shulman resigned as director at Petros Pharmaceuticals, Inc..
  - Action: resigned
  - Role: director
  source text: On October 1, 2024, John Shulman, who served as a member of the board of directors (the “Board”) of Petros Pharmaceuticals, Inc. (the “Company”), tendered his resignation from his role as director of the Company, effective as of October 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815903/000110465924106322/0001104659-24-106322-index.htm
- Executive change
  Greg Bradley resigned as director at Petros Pharmaceuticals, Inc..
  - Action: resigned
  - Role: director
  source text: On October 2, 2024, Greg Bradley, who served as a member of the Board tendered his resignation from his role as director of the Company, effective as of October 2, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815903/000110465924106322/0001104659-24-106322-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.